Alexander C. Fanaroff

3.2k total citations · 2 hit papers
104 papers, 1.8k citations indexed

About

Alexander C. Fanaroff is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Alexander C. Fanaroff has authored 104 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cardiology and Cardiovascular Medicine, 27 papers in Surgery and 18 papers in Economics and Econometrics. Recurrent topics in Alexander C. Fanaroff's work include Acute Myocardial Infarction Research (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Atrial Fibrillation Management and Outcomes (14 papers). Alexander C. Fanaroff is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Atrial Fibrillation Management and Outcomes (14 papers). Alexander C. Fanaroff collaborates with scholars based in United States, United Kingdom and Switzerland. Alexander C. Fanaroff's co-authors include Renato D. Lópes, Jay Giri, Ashwin S. Nathan, Peter W. Groeneveld, Sameed Ahmed M. Khatana, Lin Yang, Tracy Y. Wang, Howard Julien, Lauren A. Eberly and Elias J. Dayoub and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Alexander C. Fanaroff

89 papers receiving 1.8k citations

Hit Papers

Association of Race/Ethnicity, Gender, and Socioeconomic ... 2021 2026 2022 2024 2021 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
    2021 225 citations Lauren A. Eberly, Lin Yang et al. profile →
  2. Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
    2021 164 citations Lauren A. Eberly, Lin Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander C. Fanaroff United States 20 942 407 325 265 228 104 1.8k
Bart S. Ferket United States 26 545 0.6× 699 1.7× 387 1.2× 224 0.8× 191 0.8× 80 2.2k
Lori D. Bash United States 22 911 1.0× 486 1.2× 337 1.0× 176 0.7× 148 0.6× 54 2.2k
Haris Riaz United States 21 586 0.6× 500 1.2× 176 0.5× 302 1.1× 157 0.7× 81 1.7k
Maria Koh Canada 19 708 0.8× 440 1.1× 226 0.7× 216 0.8× 116 0.5× 58 1.2k
Lorenzo Fácila Spain 24 1.3k 1.3× 599 1.5× 288 0.9× 257 1.0× 168 0.7× 175 2.4k
Tiew‐Hwa Katherine Teng Singapore 26 1.7k 1.8× 226 0.6× 295 0.9× 273 1.0× 117 0.5× 92 2.2k
Vicente Bertomeu‐González Spain 27 1.9k 2.0× 565 1.4× 301 0.9× 286 1.1× 190 0.8× 186 3.0k
Alexander T. Sandhu United States 22 1.0k 1.1× 219 0.5× 218 0.7× 145 0.5× 190 0.8× 112 1.5k
Abdullah Pandor United Kingdom 28 503 0.5× 664 1.6× 159 0.5× 311 1.2× 519 2.3× 81 2.5k
Laurie A. Tomlinson United Kingdom 30 861 0.9× 360 0.9× 351 1.1× 243 0.9× 70 0.3× 115 2.9k

Countries citing papers authored by Alexander C. Fanaroff

Since Specialization
Citations

This map shows the geographic impact of Alexander C. Fanaroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander C. Fanaroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander C. Fanaroff more than expected).

Fields of papers citing papers by Alexander C. Fanaroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander C. Fanaroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander C. Fanaroff. The network helps show where Alexander C. Fanaroff may publish in the future.

Co-authorship network of co-authors of Alexander C. Fanaroff

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander C. Fanaroff. A scholar is included among the top collaborators of Alexander C. Fanaroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander C. Fanaroff. Alexander C. Fanaroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhiyuan, Alexander C. Fanaroff, Ashwin S. Nathan, et al.. (2025). Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. JACC: Cardiovascular Interventions. 18(6). 738–748. 11 indexed citations
2.
Yang, Lin, Elizabeth Genovese, Scott M. Damrauer, et al.. (2025). Racial, Socioeconomic, and Geographic Disparities in Preamputation Vascular Care for Patients With Chronic Limb-Threatening Ischemia. Circulation Cardiovascular Quality and Outcomes. 18(1). e010931–e010931.
3.
Wilson, Thomas G., Adeel Ahmed, Iqra Riaz, et al.. (2025). Precision management of coronary in-stent restenosis. Trends in Cardiovascular Medicine. 36(1). 44–55.
4.
Russell, Louise B., Kevin G. Volpp, Mitesh S. Patel, et al.. (2025). Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease. Circulation Cardiovascular Quality and Outcomes. 18(7). e011839–e011839. 1 indexed citations
5.
Fanaroff, Alexander C., Emily Kim, Charles Rareshide, et al.. (2024). A randomized controlled trial of gamification to increase physical activity among black and Hispanic breast and prostate cancer survivors: Rationale and design of the ALLSTAR clinical trial. American Heart Journal. 280. 42–51. 1 indexed citations
6.
Norton, Laurie, Charles Rareshide, Jingsan Zhu, et al.. (2024). Investigating racial and gender disparities in virtual randomized clinical trial enrollment: Insights from the BE ACTIVE study. American Heart Journal. 276. 120–124. 7 indexed citations
7.
Wojdyla, Daniel, Alexander C. Fanaroff, Andrzej Budaj, et al.. (2024). Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI. Journal of the American College of Cardiology. 84(10). 875–885. 1 indexed citations
8.
Eberly, Lauren A., Sameed Ahmed M. Khatana, Alexander C. Fanaroff, et al.. (2024). Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population. American Heart Journal. 281. 59–70.
9.
Eberly, Lauren A., Howard Julien, Jay Giri, et al.. (2023). Association between racial residential segregation and Black-White disparities in cardiovascular disease mortality. American Heart Journal. 264. 143–152. 5 indexed citations
10.
Fanaroff, Alexander C., Rim Halaby, Monika Sanghavi, et al.. (2023). Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial. American Heart Journal. 258. 85–95. 6 indexed citations
11.
Fanaroff, Alexander C., Elias J. Dayoub, Lin Yang, et al.. (2023). Development and Description of a National Cohort of Patients With Chronic Limb-Threatening Ischemia. Journal of the Society for Cardiovascular Angiography & Interventions. 2(4). 100982–100982. 3 indexed citations
12.
Fanaroff, Alexander C., et al.. (2023). Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy. Medical Clinics of North America. 108(3). 489–507.
13.
Eberly, Lauren A., Rim Halaby, Howard Julien, et al.. (2023). Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion. Journal of the American Heart Association. 12(5). e028032–e028032. 10 indexed citations
14.
Kansal, Aman, Cynthia L. Green, Eric D. Peterson, et al.. (2021). Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non–ST-Segment–Elevation Myocardial Infarction for Intensive Care Unit Admission. Circulation Cardiovascular Quality and Outcomes. 14(4). e007602–e007602. 7 indexed citations
15.
Nathan, Ashwin S., Lin Yang, Nancy Yang, et al.. (2021). Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018. Circulation Cardiovascular Quality and Outcomes. 14(11). e008260–e008260. 32 indexed citations
16.
Nathan, Ashwin S., Pratik Manandhar, Daniel Wojdyla, et al.. (2021). Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance. Journal of the American College of Cardiology. 78(22). 2213–2217. 1 indexed citations
17.
Fanaroff, Alexander C., Lin Yang, Ashwin S. Nathan, et al.. (2021). Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas. Journal of the American Heart Association. 10(17). e021456–e021456. 63 indexed citations
18.
Fanaroff, Alexander C., Robert M. Califf, Robert A. Harrington, et al.. (2020). Randomized Trials Versus Common Sense and Clinical Observation. Journal of the American College of Cardiology. 76(5). 580–589. 45 indexed citations
19.
Shavadia, Jay, Anita Y. Chen, Alexander C. Fanaroff, et al.. (2019). Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion. JACC: Cardiovascular Interventions. 12(8). 709–717. 32 indexed citations
20.
Thompson, Michael P., et al.. (2018). Focusing on the Future of Cardiovascular Outcomes Research. Circulation Cardiovascular Quality and Outcomes. 11(6). e004871–e004871. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bart S. Ferket Breakdown of academic impact, for papers by Lori D. Bash Breakdown of academic impact, for papers by Haris Riaz Breakdown of academic impact, for papers by Maria Koh Breakdown of academic impact, for papers by Lorenzo Fácila Breakdown of academic impact, for papers by Tiew‐Hwa Katherine Teng Breakdown of academic impact, for papers by Vicente Bertomeu‐González Breakdown of academic impact, for papers by Alexander T. Sandhu Breakdown of academic impact, for papers by Abdullah Pandor Breakdown of academic impact, for papers by Laurie A. Tomlinson
Rankless by CCL
2026